Today's $1 Billion Valeant Acquisition (NYSE: VRX) Details and How to Profit

Valeant Pharmaceuticals International Inc. (NYSE: VRX) confirmed its $1 billion acquisition of Sprout Pharmaceuticals Inc. today (Thursday). Money Morning Defense & Tech Specialist Michael A. Robinson has been following this M&A trend since 2014. He knew the world's top pharmaceutical companies would continue their M&A binge, and he recommended an investment to play that wave. Robinson's pick has already climbed 13% this year and still has plenty of room to run... Tags: NYSE: VRX , Valeant acquires sprout , Valeant acquisition , valeant and sprout , Valeant Sprout , Valeant sprout deal , Valeant stock , Valeant stock price , VRX stock , VRX stock price To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Today's $1 Billion Valeant Acquisition (NYSE: VRX) Details and How to Profit appeared first on Money Morning - We Make Investing Profitable .